Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01

NCT05897957 · clinicaltrials.gov ↗
ENROLLING_BY_INVITATION
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

BlueRock Therapeutics